Login

Tourmaline Bio, Inc. SEC Filings

Filed On Filing
14 Nov 2025 EFFECT
14 Nov 2025 EFFECT
14 Nov 2025 SCHEDULE 13G/A
07 Nov 2025 FORM 15-12G
28 Oct 2025 Form 4: Siegall Clay B, Director

Disposed of 51,800 Employee Stock Option (Right to Buy) (Disposition to Issuer)

28 Oct 2025 Form 4: Thiara Parvinder, Director

Disposed of 83,782 shares (Tender Offer) · Disposed of 36,800 Employee Stock Option (Right to Buy) (Disposition to Issuer)

28 Oct 2025 Form 4: Srivastava Sapna, Director

Disposed of 518 shares (Tender Offer) · Disposed of 46,800 Employee Stock Option (Right to Buy) (Disposition to Issuer)

28 Oct 2025 Form 4: Mcdade Mark, Director

Disposed of 742,209 shares (Tender Offer) · Disposed of 46,800 Employee Stock Option (Right to Buy) (Disposition to Issuer)

28 Oct 2025 Form 4: Kantoff Aaron, Director

Disposed of 88,281 shares (Tender Offer) · Disposed of 26,800 Employee Stock Option (Right to Buy) (Disposition to Issuer)

28 Oct 2025 Form 4: Castelein Caley, Director

Disposed of 947,936 shares (Tender Offer) · Disposed of 36,800 Employee Stock Option (Right to Buy) (Disposition to Issuer)

28 Oct 2025 Form 4: Johnson Kevin Bruce, Chief Regulatory Officer

Disposed of 40,538 shares (Tender Offer) · Returned 11,046 shares to the issuer · Disposed of 200,920 Employee Stock Option (Right to Buy) (Disposition to Issuer)

28 Oct 2025 Form 4: Jones Susan Dana, Chief Technology Officer

Disposed of 19,782 shares (Tender Offer) · Returned 3,152 shares to the issuer · Disposed of 180,993 Employee Stock Option (Right to Buy) (Disposition to Issuer)

28 Oct 2025 Form 4: Middlekauff W Bradford, CBO, GC and Secretary

Disposed of 60,988 shares (Tender Offer) · Returned 8,213 shares to the issuer · Disposed of 229,765 Employee Stock Option (Right to Buy) (Disposition to Issuer)

28 Oct 2025 Form 4: Robinson Ryan F., CFO

Disposed of 14,366 shares (Tender Offer) · Disposed of 176,245 Employee Stock Option (Right to Buy) (Disposition to Issuer)

28 Oct 2025 Form 4: Kulkarni Sandeep Chidambar, Director

Disposed of 731,664 shares (Tender Offer) · Returned 30,387 shares to the issuer · Disposed of 983,685 Employee Stock Option (Right to Buy) (Disposition to Issuer)

28 Oct 2025 Form 3: Novartis Ag, 10% owner

Holds 24,030,382 shares of Common Stock, par value $0.0001

28 Oct 2025 S-8 POS
28 Oct 2025 S-8 POS
28 Oct 2025 S-8 POS
28 Oct 2025 S-8 POS

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support